Isabelle Chéreau
Impact in
- Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Botulinum Toxin and Related Neurological Disorders
- Psychiatry and Mental health top 10%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
Papers in
-
- Neurological disorders and treatments 5
- Parkinson's Disease Mechanisms and Treatments 5
- Parkinson's Disease and Spinal Disorders 2
-
- Schizophrenia research and treatment 8
- Co-authors
- Pierre‐Michel Llorca (8 shared papers)Franck Durif (3 shared papers)Paul Krack (4 shared papers)Christophe Lançon (2 shared papers)Claire Ardouin (3 shared papers)PM Llorca (3 shared papers)Pierre Pollak (1 shared paper)Eugénie Lhommée (1 shared paper)
- Journals
- European Psychiatry (2 papers)Clinical Rehabilitation (1 paper)Neurology (1 paper)European Neuropsychopharmacology (1 paper)Psychological Medicine (1 paper)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Isabelle Chéreau
22 papers receiving 466 citations
Peers
Comparison fields: 5 of 55
- Neurology 279
- Psychiatry and Mental health 118
- Biological Psychiatry 13
- Clinical Psychology 89
- Cellular and Molecular Neuroscience 71
Countries citing papers authored by Isabelle Chéreau
This map shows the geographic impact of Isabelle Chéreau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Chéreau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Chéreau more than expected).
Fields of papers citing papers by Isabelle Chéreau
This network shows the impact of papers produced by Isabelle Chéreau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Chéreau. The network helps show where Isabelle Chéreau may publish in the future.
Co-authors
The 25 scholars most cited alongside Isabelle Chéreau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 91 | |
| 2 | 2015 | 83 | |
| 3 | 2002 | 69 | |
| 4 | 2016 | 54 | |
| 5 | 2011 | 38 | |
| 6 | 2016 | 31 | |
| 7 | 2020 | 28 | |
| 8 | 2020 | 15 | |
| 9 | 2010 | 13 | |
| 10 | 2005 | 12 | |
| 11 | 2005 | 12 | |
| 12 | [Interest of the use of pindolol in the treatment of depression: review]. | 2004 | 10 |
| 13 | 2022 | 8 | |
| 14 | 2021 | 6 | |
| 15 | 2004 | 5 | |
| 16 | 2008 | 3 | |
| 17 | 2014 | 3 | |
| 18 | 2018 | 2 | |
| 19 | 2002 | 2 | |
| 20 | 2008 | 1 |
About Isabelle Chéreau
Isabelle Chéreau is a scholar working on Neurology, Psychiatry and Mental health, Clinical Psychology, Philosophy and Cognitive Neuroscience, having authored 23 papers that have together received 488 indexed citations. Recurring topics across this work include Schizophrenia research and treatment (8 papers), Neurological disorders and treatments (5 papers), Parkinson's Disease Mechanisms and Treatments (5 papers), Mental Health and Psychiatry (4 papers), Mental Health Treatment and Access (2 papers), Parkinson's Disease and Spinal Disorders (2 papers), Personality Disorders and Psychopathology (1 paper) and Forensic Toxicology and Drug Analysis (1 paper). The work is most often cited by research in Neurology (279 citations), Psychiatry and Mental health (118 citations), Biological Psychiatry (13 citations), Clinical Psychology (89 citations) and Cellular and Molecular Neuroscience (71 citations). Isabelle Chéreau has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Pierre‐Michel Llorca, Franck Durif, Paul Krack, Christophe Lançon, Claire Ardouin, PM Llorca, Pierre Pollak, Eugénie Lhommée, Isabelle Rieu and I. de Chazeron. Their work appears in journals such as European Psychiatry, Clinical Rehabilitation, Neurology, European Neuropsychopharmacology and Psychological Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.